Lundbeck LLC
Privately held: no public share price
Assets
(2 total)
2Total Assets
2Approved
0Phase 3 / Filed
0Phase 1–2 / Early
3Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Approved | GABA-A receptorSmall molecule | EpilepsyDevelopmental and Epileptic EncephalopathiesLennox-Gastaut Syndrome | |
| Approved | GABA transaminase (GABA-T)Small molecule | EpilepsyDevelopmental and Epileptic Encephalopathies Focal Onset Seizures |
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Financial reports
No financial reports recorded.